...
首页> 外文期刊>Intensive care medicine >Safety of performing fiberoptic bronchoscopy in critically ill hypoxemic patients with acute respiratory failure.
【24h】

Safety of performing fiberoptic bronchoscopy in critically ill hypoxemic patients with acute respiratory failure.

机译:重症低氧血症急性呼吸衰竭患者行纤维支气管镜检查的安全性。

获取原文
获取原文并翻译 | 示例
           

摘要

The safety of fiberoptic bronchoscopy (FOB) in nonintubated critically ill patients with acute respiratory failure has not been extensively evaluated. We aimed to measure the incidence of intubation and the need to increase ventilatory support following FOB and to identify predictive factors for this event.A prospective multicenter observational study was carried out in eight French adult intensive care units. The study included 169 FOB performed in patients with a PaO(2)/FiO(2) ratio ≤ 300. The main end-point was intubation rate. The secondary end-point was rate of increased ventilatory support defined as an increase in oxygen requirement >50 %, the need to start noninvasive positive pressure ventilation (NI-PPV) or increase NI-PPV support.Within 24 h, an increase in ventilatory support was required following 59 bronchoscopies (35 %), of which 25 (15 %) led to endotracheal intubation. The existence of chronic obstructive pulmonary disease (COPD; OR 5.2, 95 % CI 1.6-17.8; p = 0.007) or immunosuppression (OR 5.4, 95 % CI 1.7-17.2; p = 0.004] were significantly associated with the need for intubation in the multivariable analysis. None of the baseline physiological parameters including the PaO(2)/FiO(2) ratio was associated with intubation.Bronchoscopy is often followed by an increase in ventilatory support in hypoxemic critically ill patients, but less frequently by the need for intubation. COPD and immunosuppression are associated with the need for invasive ventilation in the 24 h following bronchoscopy.
机译:尚未广泛评估非插管危重患者急性呼吸衰竭的纤维支气管镜检查(FOB)的安全性。我们的目的是测量FOB后插管的发生率以及增加通气支持的必要性,并确定该事件的预测因素。在法国的八个成人重症监护室进行了一项前瞻性多中心观察性研究。该研究包括在PaO(2)/ FiO(2)比率≤300的患者中进行的169次FOB。主要终点是插管率。次要终点是通气支持增加的速率,定义为需氧量增加> 50%,需要开始无创正压通气(NI-PPV)或增加NI-PPV支持.24小时内通气增加59例支气管镜检查(35%)后需要支持,其中25例(15%)导致气管插管。慢性阻塞性肺疾病(COPD; OR 5.2,95%CI 1.6-17.8; p = 0.007)或免疫抑制(OR 5.4,95%CI 1.7-17.2; p = 0.004)的存在与需要进行气管插管显着相关。包括PaO(2)/ FiO(2)之比在内的基本生理参数均未与插管相关。在低氧血症危重病人中,支气管镜检查通常伴随着通气支持的增加,但由于需要COPD和免疫抑制与支气管镜检查后24小时需要有创通气有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号